ATE524203T1 - Hydrogel für zellspezifisches einwachsen - Google Patents

Hydrogel für zellspezifisches einwachsen

Info

Publication number
ATE524203T1
ATE524203T1 AT04800661T AT04800661T ATE524203T1 AT E524203 T1 ATE524203 T1 AT E524203T1 AT 04800661 T AT04800661 T AT 04800661T AT 04800661 T AT04800661 T AT 04800661T AT E524203 T1 ATE524203 T1 AT E524203T1
Authority
AT
Austria
Prior art keywords
biomaterial
ingrowth
cells
cell
peptide sequences
Prior art date
Application number
AT04800661T
Other languages
English (en)
Inventor
Peter Zilla
Neil Davies
Terri Dower
Mona Bracher
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Application granted granted Critical
Publication of ATE524203T1 publication Critical patent/ATE524203T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25Peptides having up to 20 amino acids in a defined sequence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow
    • A61L2300/604Biodegradation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04800661T 2003-11-03 2004-11-03 Hydrogel für zellspezifisches einwachsen ATE524203T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51711303P 2003-11-03 2003-11-03
PCT/US2004/036591 WO2005042046A1 (en) 2003-11-03 2004-11-03 Hydrogel providing cell-specific ingrowth

Publications (1)

Publication Number Publication Date
ATE524203T1 true ATE524203T1 (de) 2011-09-15

Family

ID=34549591

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04800661T ATE524203T1 (de) 2003-11-03 2004-11-03 Hydrogel für zellspezifisches einwachsen

Country Status (6)

Country Link
US (1) US20050119762A1 (de)
EP (1) EP1691854B1 (de)
AT (1) ATE524203T1 (de)
CA (1) CA2544779A1 (de)
WO (1) WO2005042046A1 (de)
ZA (1) ZA200604497B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914807B2 (en) * 2007-03-05 2011-03-29 Boston Scientific Scimed, Inc. Medical devices having improved performance
EP2014256A1 (de) * 2007-07-12 2009-01-14 Straumann Holding AG Verbundmaterial zur Knochenreparatur
US20090069904A1 (en) * 2007-09-12 2009-03-12 Applied Medical Research Biomaterial including micropores
WO2009126742A2 (en) * 2008-04-08 2009-10-15 Appian Labs, Llc Enzyme mediated delivery system
WO2010006200A2 (en) * 2008-07-09 2010-01-14 Board Of Regents, The University Of Texas System Triggered release of drugs from polymer particles
US9345662B2 (en) * 2008-11-19 2016-05-24 Rutgers, The State University Of New Jersey Degradable hydrogel compositions and methods
US20100124533A1 (en) * 2008-11-20 2010-05-20 Medtronic Vascular, Inc. Large Animal Model for Human-Like Advanced Atherosclerotic Plaque
WO2013033717A1 (en) * 2011-09-02 2013-03-07 The Regents Of The University Of California Enzyme responsive nanocapsules for protein delivery
US20150025651A1 (en) * 2012-02-14 2015-01-22 Straumann Holding Ag Bone repair material
EP2814520B1 (de) 2012-02-14 2016-11-02 Straumann Holding AG Knochenreparaturmaterial
WO2016011387A1 (en) 2014-07-17 2016-01-21 The Regents Of The University Of California Controllable self-annealing microgel particles for biomedical applications
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
US20180008646A1 (en) * 2015-01-30 2018-01-11 Nissan Chemical Industries, Ltd. Method for cultivating vascular smooth muscle cells
WO2017142879A1 (en) 2016-02-16 2017-08-24 The Regents Of The University Of California Methods for immune system modulation with microporous annealed particle gels
CA3043708A1 (en) * 2016-11-17 2018-05-24 Cleveland State University Chip platforms for microarray 3d bioprinting
EP3554548A4 (de) * 2016-12-19 2020-08-19 The Regents of The University of California Nicht brechbare tablettenformulierungen
CN110446508A (zh) 2016-12-29 2019-11-12 泰普治疗公司 用于治疗医疗植入物部位的方法和系统
CN112516385A (zh) * 2020-11-16 2021-03-19 清华大学 一种用于神经再生的定向纤维蛋白与多肽互穿网络复合水凝胶及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5330911A (en) * 1989-09-28 1994-07-19 Board Of Regents, The University Of Texas System Surfaces having desirable cell adhesive effects
US5278063A (en) 1989-09-28 1994-01-11 Board Of Regents The University Of Texas System Chemical modification of promote animal cell adhesion on surfaces
US5626863A (en) * 1992-02-28 1997-05-06 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5414135A (en) * 1991-12-30 1995-05-09 Sterling Winthrop Inc. Vinyl sulfone coupling of polyoxyalkylenes to proteins
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US6458889B1 (en) * 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
US6132765A (en) * 1996-04-12 2000-10-17 Uroteq Inc. Drug delivery via therapeutic hydrogels
US5766240A (en) * 1996-10-28 1998-06-16 Medtronic, Inc. Rotatable suturing ring for prosthetic heart valve
US20020168718A1 (en) * 1997-04-03 2002-11-14 California Institute Of Technology Enzyme-mediated modification of fibrin for tissue engineering
ATE484541T1 (de) * 1997-04-21 2010-10-15 California Inst Of Techn Multifunctionelle polymer-beschichtung
US6110487A (en) * 1997-11-26 2000-08-29 Keraplast Technologies Ltd. Method of making porous keratin scaffolds and products of same
US6540780B1 (en) * 1998-11-23 2003-04-01 Medtronic, Inc. Porous synthetic vascular grafts with oriented ingrowth channels
AU773914B2 (en) 1999-02-01 2004-06-10 Eidgenossische Technische Hochschule Zurich Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
WO2000048530A1 (en) * 1999-02-16 2000-08-24 Talison Research, Inc. Multilayer and multifunction vascular graft
JP2002538914A (ja) * 1999-03-18 2002-11-19 コリア アドバンスト インスティテュート オブ サイエンス アンド テクノロジ− 生体組織工学用多孔性生分解性生適合性高分子支持体の製造方法
WO2000060956A1 (en) * 1999-04-12 2000-10-19 Cornell Research Foundation, Inc. Hydrogel-forming system with hydrophobic and hydrophilic components
US6702848B1 (en) * 1999-07-20 2004-03-09 Peter Paul Zilla Foam-type vascular prosthesis with well-defined anclio-permissive open porosity
US6554857B1 (en) * 1999-07-20 2003-04-29 Medtronic, Inc Transmural concentric multilayer ingrowth matrix within well-defined porosity
US6620356B1 (en) * 2000-04-18 2003-09-16 Integra Lifesciences Corp. Porous constructs fabricated by gas induced phase inversion
US20030055494A1 (en) * 2001-07-27 2003-03-20 Deon Bezuidenhout Adventitial fabric reinforced porous prosthetic graft
US7022135B2 (en) * 2001-08-17 2006-04-04 Medtronic, Inc. Film with highly porous vascular graft prostheses
US7247609B2 (en) * 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
US20050222688A1 (en) * 2002-05-10 2005-10-06 Medtronic, Inc. Transmural concentric multilayer ingrowth matrix within well-defined porosity
US7955788B2 (en) * 2003-10-30 2011-06-07 Medtronic, Inc. Bioprosthetic tissue preparation with synthetic hydrogels

Also Published As

Publication number Publication date
US20050119762A1 (en) 2005-06-02
ZA200604497B (en) 2007-12-27
EP1691854A1 (de) 2006-08-23
CA2544779A1 (en) 2005-05-12
WO2005042046A1 (en) 2005-05-12
EP1691854B1 (de) 2011-09-14

Similar Documents

Publication Publication Date Title
ZA200604497B (en) Hydrogel providing cell-specific ingrowth
DE60032789D1 (de) Mikrostruktur-stentstruktur
WO2003039489A3 (en) Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
ATE342962T1 (de) Zusammensetzungen und verfahren für verbesserte zellkultur
DE69916807D1 (de) Kostimulatorische blockade und gemischter chimerismus in allotransplantationen
DE602005015302D1 (en) Nkg2d modulation
EP1668008A4 (de) Nitrosierte und nitrosylierte diuretische verbindungen, zusammensetzungen und anwendungsverfahren
SG154447A1 (en) Endoprosthetic elements for an ankle joint
PL337019A1 (en) Peptide-coated implants and method of obtaining them
WO2003092471A3 (en) Cell-seeded extracellular matrix grafts
WO2004015077A3 (en) Compositions and methods for neural differentiation of embryonic stem cells
ATE480265T1 (de) Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen
ATE287736T1 (de) Humanisierte biomaterialien enthaltend monozyten oder makrophagen, ein verfahren zu ihrer herstellung und ihre anwendungen
DE602004024312D1 (de) Verwendung von cxcl6 chemokin bei der prävention oder reparatur von knorpeldefekten
DE69832387D1 (de) Vinylidenfluorid copolymer für feste gelförmige elektrolytherstellung, fester elektrolyt und batterie
DE602004027310D1 (de) Herstellungsverfahren zur produktion aktiver und löslicher proteine in prokaryonten und polycistronische vektoren dafür
EP2527427A3 (de) Multipotente Postnatale Stammzellen aus dem humanen periodontalen Ligament und deren Verwendung
CY1109815T1 (el) Μεθοδοι διασταυρουμενης συμβατοτητας ειδικες δοτη
AU2003287521A1 (en) Pluripotent cells from monocytes, and methods of making and using pluripotent cells
DE69832989D1 (de) Genetisch manipulierte zellen die knochenmorphogeneseproteinen exprimieren
DK1537229T3 (da) Fremgangsmåder til produktion af biologiske stoffer i pigmentmanglende mutanter af Bacillus-celler
ATE395092T1 (de) Zementierbare endoprothesen
ATE191223T1 (de) Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander
DE60323267D1 (en) Rna-bioassay
WO2003059932A3 (en) Methods of inducing or enhancing connective tissue repair

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties